PolyBio Research Foundation today announced the second phase of its LongCovid Research Consortium (LCRC), including the distribution of $15M to fund research and clinical trials.
Avails Medical, Inc., a leader in the development of rapid, automated and fully electrical antibiotic susceptibility testing (AST) technologies, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking eQUANTTM system.
A new study published by Nutrients reports that consuming 100% orange juice prior to a meal, when compared to sugar-sweetened, orange-flavored drinks, suppresses food intake at the next meal and results in lower daily blood glucose concentrations in healthy, normal-weight adults.1
Wasatch Biolabs (WBL), a subsidiary of Renew Biotechnologies and a certified Oxford Nanopore Technologies' laboratory, launches a proprietary Targeted DNA Methylation Sequencing Service for researchers and clinical service providers.
VST Bio Corp. a leader in the development of innovative biologics to treat acute and chronic cardiovascular disease, presented data from a recent large animal study performed by VST Bio and Yale University demonstrating that a single iv bolus of VST-002 led to meaningful reduction in brain damage and improved function in an advanced model of ischemic stroke.
CSOFT Health Sciences, leaders in clinical trial translation, are pleased to announce the launch of their co-authored white paper for medical device manufacturers seeking re-certification under the updated EU Medical Device Regulation (EU MDR), in collaboration with partner organizations Gouya Insights and GCP-Service International Ltd. & Co.KG to jointly offer manufacturers an end-to-end platform for establishing conformity with policies set to take effect by January 2028.
The RejuvenAir System is a minimally invasive medical device therapy which aims to target the underlying cause of COPD with Chronic Bronchitis.
OriGene is excited to announce that it has been selected as the 2023 Bioz Stars Award Winner in the following categories: Cloning, Vectors, & CRISPR.
Qorvis announces the appointment of Dr. Colleen Pietras, M.D., to the position of Chief Medical Officer. A cardiac surgeon with experience at institutions including Yale and the Mayo Clinic, Dr. Pietras will enrich the communications support Qorvis provides to clients in the healthcare, pharmaceuticals, life sciences, and medical device sectors, among others.
Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that the key development work for the Flaskworks manufacturing system has been completed and an external vendor has been engaged to produce GMP-grade units of the system.
Koning Health, a pioneer in advanced medical imaging technology, is proud to announce the successful showcasing of the Koning Vera Breast CT at the prestigious Arab Health exhibition in Dubai.
Madison Wisconsin based Imbed Biosciences, Inc has been awarded a Technology Breakthrough designation for PelashieldAM™ with Premier, Inc. through its Kiindo™ pediatric performance group and collaborative.
Stuart Therapeutics, Inc. ("Stuart"), a clinical-stage biopharmaceutical company with candidate therapeutics in various phases of clinical development, today announced that it has appointed Jodi Luchs, MD to the position of Chief Medical Officer, and Don Stires to the position of Chief Financial Officer.
Harmonic Discovery (the "Company"), a precision pharmacology company focusing on developing next generation kinase inhibitors, today announced an exclusive licensing agreement of a novel small-molecule drug candidate for the treatment of FLT3 mutated acute myeloid leukemia (AML) from BioVentures (University of Arkansas for Medical Sciences) and UC San Francisco (UCSF).
Lion Street Medical, LLC is pleased to announce the successful acquisition of Pensar Medical, LLC, a prominent medical device company specializing in wound care.
Sechrist Industries, a leader in hyperbaric technology, is proud to announce the launch of two groundbreaking products: eHEAL and the 3300HM Hyperbaric Chamber.
The U.S. Food and Drug Administration has placed a purchase order (75F40123P00369) committing to an annual subscription of digiM I2S, a fully integrated image processing platform based on digiM's proprietary cloud technology.
Quiet Events®, a leader in Silent Disco events and rentals, announces an exciting new partnership with the Day By Day Project, a pioneer in the innovative Memory Disco™ program.
Protocol BowProofPilot , the leading platform for clinical trial automation & guidance, today announced its "Protocol Bowl" event at the 15th Annual SCOPE Summit for clinical trial operations executives the day after Sunday's Big Game.
FDA's De Novo approval of BrainSee represents a major advancement in Alzheimer's diagnostics. Utilizing cutting-edge image processing and medical AI, BrainSee establishes a new standard for predicting progression from amnestic mild cognitive impairment (aMCI) to Alzheimer's dementia. This breakthrough is a significant step in proactive brain health management, offering a fully non-invasive, convenient, and globally accessible screening solution, to be prioritized before other tests or treatments.
The AccuSignal™ Nuclease ELISA Kit is designed to detect any Serratia marcescens endonuclease, such as Benzonase®, DENARASE®, and Turbonuclease, to evaluate manufacturing processes for biological therapeutics, gene therapy vectors, vaccine preparations, and more.
Kansas City University (KCU) today announced plans for a new Center for Population Health and Equity (CPHE) that will systematically educate students and engage communities in addressing the factors outside of the health care system that impact health -- the social and structural determinants that are the largest contributors to health inequities.
3Spine, Inc., a medical device company developing a transformational alternative to lumbar spinal fusion, today announced achievement of US clinical trial enrollment, with 151 completed MOTUS lumbar total joint replacement surgeries and 174 real-world posterior lumbar fusions as of December 2023.
HCA Florida Fort Walton-Destin Hospital Sets Benchmark for Perfusion Care and Patient Safety.
omprehensive Care Services (CCS) has become the world's largest perfusion provider with the acquisition of German-based Life Systems. This move unites two leaders in perfusion care, expanding global access to top-tier patient services.
G3 Therapeutics ("G3"), a global leader in the use of multiomic biological Big Data, has initiated a groundbreaking initiative to unravel the contribution of Lipoprotein(a) ["Lp(a)"] to cardiovascular disease (CVD).
Today marks a significant milestone for Prendio and BioProcure, industry leaders in cloud-based eProcurement software and procure-to-pay support services for the life sciences sector, as they proudly announce the appointment of Eric Meizlish as their new Chief Executive Officer.
Cardionomic, Inc., a Minneapolis medical device company, is pleased to announce the completion of enrollment in both their STIM-ADHF and STOP-ADHF pilot studies.
Urology of Virginia announces that Dr. Joshua Langston has been elected Managing Partner and Chief Executive Officer, as of January 1, 2024.
Zymo Research, a leading provider of innovative life science technologies, has been honored with the Top Workplaces USA 2023 and Culture Excellence 2023 awards
One-fifth of U.S. adults said that they would not be able to isolate a sick household member in a separate bedroom and bathroom in the case of an infectious disease outbreak, yet 75% believe that an infectious disease outbreak is moderately or highly likely to occur within the U.S. during the next year, according to a data brief issued by Heluna Health this week.
WRQ Sciences and Superfluid Dx, Inc., announced today the completion of an oversubscribed Series A financing led by WRQ Sciences. With this transaction, WRQ Sciences has acquired majority ownership in the Alzheimer's Disease (AD) diagnostics company, Molecular Stethoscope, Inc., which is now renamed Superfluid Diagnostics, Inc. The Alzheimer's Drug Discovery Foundation's (ADDF) Diagnostics Accelerator (DxA) participated in the Series A financing.
Across the United States, about 2 million people are living with an amputation and another 185,000 amputations occur every year, according to the Amputee Coalition, a Washington, DC-based support group. About 54% of these lost limbs were caused by vascular disease, including diabetes and peripheral arterial disease (PAD)
On April 8, 2024, a Total Solar Eclipse will sweep across the United States from Texas to Maine sending millions of Americans into darkness.
Martin Green, Scientia Professor and world-leading silicon cell pioneer at the University of New South Wales (UNSW) Sydney, Australia, has won the 2023 Leigh Ann Conn Prize for Renewable Energy from the University of Louisville.
Alliance for Multispecialty Research (AMR), a leading integrated research site organization, has acquired Affinity Health. Affinity Health, founded in 2015.
The Association for the Accreditation of Human Research Protection Programs has awarded accreditation to Miami Cancer Institute, part of Baptist Health South Florida located in Miami, Florida. The institute joins some of the nation's most respected cancer organizations in attaining what is widely regarded as the global mark of a quality research program
AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on discovery and development of innovative and proprietary cell-based therapeutic products, today announced an amendment of its worldwide collaboration and license agreement with Janssen Biotech, Inc. (Janssen), a Johnson & Johnson company.
Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell-targeting photoimmunotherapy treatments based on its proprietary Alluminox™ platform, today announced that the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference being held January 8-11, 2024.
FluidForm Bio, a leader in developing life-like human tissue to treat disease, shares recent advancements in building human cardiac tissues using FRESH™ 3D bioprinting. Recently published in APL Bioengineering, the research article FRESH™ 3D bioprinted cardiac tissue, a bioengineered platform for in vitro pharmacology addresses the critical need for a predictive model of human cardiac physiology in drug development.
Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ: LUCY; LUCYW), the developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, is pleased to announce a key update to the Company's Lucyd app for Android, the first app to enable a voice interface for ChatGPT.
Researchers from Analysis Group, a global leader in health economics and outcomes research (HEOR), have coauthored a follow-up analysis of patient-reported outcomes (PROs) that evaluated outcomes three years after initiation of dupilumab among adults with atopic dermatitis (AD).
Amidst the demand for innovative dry eye solutions, a groundbreaking collaboration between distinguished scientists and healthcare experts has been published in an exceptional white paper revealing the questions surrounding Dry Eye Disease (DED).
TriNetX, LLC ("TriNetX"), a global network of healthcare organizations driving real-world research to accelerate the development of new therapies, proudly participated in an important video series, "Connecting the Dots." The series, presented by MedTech Europe with a film produced for TriNetX by BBC StoryWorks Commercial Productions, underscores the pivotal role of medical technologies in shaping the future of healthcare.
A $25 million gift from the Gerald A. and Karen A. Kolschowsky Foundation is the latest in a series of family donations spurring transformative research and drawing top-tier physicians to Sarasota Memorial Health Care System (SMH) and the southwest Florida region.
Researchers at the University of Central Florida College of Medicine (UCF COM) in Orlando, Florida completed research that is very promising in the treatment of Parkinson's disease
A partnership between ARUP Laboratories and Medicover has made a new companion diagnostic, and thereby a new gene therapy, more accessible to patients in the European Union.
Koning Health, a leader in innovative breast imaging technology, is proud to announce its triumphant participation at the Radiological Society of North America (RSNA) 2023 Annual Meeting. The event, renowned for its educational courses, scientific sessions, and technical exhibits, provided an ideal platform for Koning to showcase its revolutionary product, the Koning Vera Breast CT.
Presage Biosciences, a pioneering translational oncology company whose mission is to use CIVO and spatial molecular profiling to understand the complexity of drug response in the tumor microenvironment (TME), has entered into an agreement with AstraZeneca (LSE/STO/Nasdaq: AZN), a global biopharmaceutical company.
ARUP Laboratories today released the company's public comment on the FDA's proposed rule to regulate laboratory-developed tests (LDTs) as medical devices, urging the agency to withdraw the rule.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right